MARCH 15, 2007
VOLUME 4 NO. 5

PATIENTS & PRACTICE

Better heart risk test, for her

C-reactive protein, history help sort mid-risk group


Reynolds Risk Score at a glance

The seven criteria that determine a woman's heart risk score are:

  1. Age
  2. Current smoking status: the most definitive risk factor
  3. Systolic blood pressure: the upper blood pressure measurement, regardless if BP medications are being taken; for most women, the optimal systolic BP value is less than 120 mm/Hg
  4. Total cholesterol: the average of two measurements from a standard blood test is recommended; for most women, the optimal value is less than 160 mg/dL
  5. High-density lipoprotein cholesterol: the average of two measurements from a standard blood test is recommended; for most women, the optimal value is greater than 60 mg/dL
  6. High-sensitivity C-reactive protein: the lower of two measurements from a standard blood test is recommended, particularly if the initial value is greater than 5 mg/L; for most women, the optimal value is less than 0.5 mg/L
  7. Parental history of myocardial infarction: the test considers parental history positive if either parent suffered an MI before age 60

American researchers have devised a simple but innovative test that could help physicians better predict women's odds of developing heart disease.

Standard methods of risk assessment developed decades ago were generally patterned on male population models. They've proven less effective at determining whether a woman will develop heart disease — particularly the millions of women considered to be at intermediate risk, for whom preventive treatment is not standardized. But using the Reynold's Risk Score would reclassify 50% of those women into more well-defined high- or low-risk categories, allowing for more effective treatment. "[The test] lets doctors know which risk factors need to be targeted most, and how aggressively they need to be treated," said Dr Samia Mora, a cardiologist and member of the research team led by Dr Paul Ridker at Brigham and Women's Hospital, Boston.

TWO TO TANGO
According to its developers, the test's increased accuracy is due to the inclusion of two new risk predictors: high-sensitivity C-reactive protein and parental history of myocardial infarction before age 60.

"These two, easily determined risk factors — when taken with traditional factors — give us a lot more information about a woman's chances of getting heart disease in the next 10 or more years It's almost like looking into her future and being able to stop a heart attack or stroke before it happens," Dr Mora explained.

The Reynold's Risk Score is based on information culled from the Women's Health Study. Dr Ridker's team studied over 24,000 initially healthy participants, choosing those over age 45 without diabetes. Follow-up was an average of 10.2 years. Researchers used information from two-thirds of the group to create the risk score and the remaining one-third to validate its conclusions. Their findings were published in the February 14 issue of JAMA.

MAKING THE CUT
Dr Ridker's team originally looked at 35 variables — some traditional, others controversial. "Previous studies made assumptions of which factors to include when assessing risk. We included all of them to determine which ones were actually predictive of cardiovascular events in women," said Dr Mora, adding that smoking is still the most important risk factor.

Most of the risk factors they looked at didn't demonstrate a strong enough effect on the incidence of heart disease. The only two new ones that merited inclusion were C-reactive protein and family history, though Dr Mora said a few, like lipoprotein-a, made the short list. The other five standard risk factors included in the score are age, smoking, systolic blood pressure, total cholesterol and high-density lipoprotein.

"Previous risk assessment models targeted high-risk individuals, who would be started on medication, while everyone else would simply be given general public health advice. This worked well for women at low-risk, but we didn't know what to do with all the intermediate-risk women — 10 million in the US alone," explained Dr Mora. "With the Reynolds Risk Score, we are able to reclassify a quarter of these women as high-risk and another quarter as low-risk. We know who will benefit from aggressive statin or aspirin treatment, or for whom it would be sufficient to eat a bit less and exercise a bit more," she added.

SEE FOR YOURSELF
Take two women, both considered to be at intermediate (5-20%) risk of developing heart disease according to standard assessment. "If all of their variables are equal, except one's high-sensitivity C-reactive protein measurement is low and the other's is high, it may reclassify them into low- and high-risk categories, respectively. Instead of giving both of them medication or general health advice, each woman receives the treatment that's appropriate for her," said Dr Mora.

She encourages doctors to visit ReynoldsRiskScore.org, to try the user-friendly application for themselves — or plug in a patient's numbers while they're still in your office. "You can show them how — even if all their other risk factors stay the same — the likelihood of a cardiovascular event increases as they get older. Or demonstrate how their risk can often be sharply decreased if they stop smoking or reduce their blood pressure," said Dr Mora. If a patient knows their real odds of developing heart disease, she said, they will be more motivated to change their risk profile.

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T. (514) 995-4398